Get the latest news, insights, and market updates on ARDT (Ardent Health, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Ardent Health Announces Third Quarter 2025 Results Conference Call and Webcast Date
BRENTWOOD, Tenn., October 22, 2025--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its third quarter 2025 results after the market closes on Wednesday, November 12, 2025. A conference call will be held the following day, Thursday, November 13, 2025, at 9 a.m. ET to review the Company’s financial results and conduct a question-and-answer session. Oct 22, 2025 - $ARDT
Elevance Health (ELV) Tops Q3 Earnings and Revenue Estimates
Elevance Health (ELV) delivered earnings and revenue surprises of +21.08% and +1.15%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock? Oct 21, 2025 - $ARDT
Ardent Announces Successful Amendment and Extension of Term Loan Facility
BRENTWOOD, Tenn., September 22, 2025--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it has successfully amended and extended its $777.5 million Term Loan Facility. The new terms reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 2.75% to Term SOFR plus 2.25%. The transaction extends the maturity of the facility to September 2032. Sep 22, 2025 - $ARDT
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" lets us enhance your experience and provide personalized content and ads.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple